This brand name is authorized in Nigeria.
The drug EPISTAMINE contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
MZ1131787D - NAPHAZOLINE HYDROCHLORIDE
|
|
Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity. |
|
2
|
UNII
V1Q0O9OJ9Z - CHLORPHENIRAMINE MALEATE
|
|
Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-101047 | Solution/Drops | Epistamine Eye & Nose Drops SOL_DROPS 0.5 mg/mL; 0.5 mg/mL 15 mL (in plastic dropper bottle) | Clear, colourless solution preserved in a tight, light resistant plastic dropper bottle | 25/09/2024 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-101047 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.